Biote Corp. BTMD Product — Inventory Adjustments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Biote Corp. in its filing.
Tagged under the XBRL concept us-gaap:InventoryAdjustments.
The official record: Biote Corp.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biote Corp.'s product — inventory adjustments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Biote Corp.'s product — inventory adjustments?
- Biote Corp. (BTMD) reported product — inventory adjustments of $2.1M in Q1 2026.
- How has Biote Corp.'s product — inventory adjustments changed year-over-year?
- Biote Corp.'s product — inventory adjustments increased by 1.2% year-over-year, from $2.07M to $2.1M.
- What is the long-term trend for Biote Corp.'s product — inventory adjustments?
- Over 2 years (2023 to 2025), Biote Corp.'s product — inventory adjustments has grown at a 41.7% compound annual growth rate (CAGR), from $4.98M to $9.99M.
- What does product — inventory adjustments mean?
- This reflects the cumulative valuation allowances, including reserves for obsolescence, shrinkage, or lower-of-cost-or-market adjustments applied to the product segment's inventory. These adjustments provide insight into the quality of the inventory and the company's ability to accurately forecast demand for its hormone optimization products. Frequent or large adjustments may signal potential issues with product lifecycle management or inventory turnover.